Destiny Wealth Partners’s AbbVie ABBV Stock Holding History

Destiny Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Sell	5,066 -495	-9%	-$106K	0.18%	65
2026 Q1	$1.21M	Buy	5,561 +506	+10%	+$112K	0.13%	88
2025 Q4	$1.12M	Sell	5,055 -757	-13%	-$172K	0.13%	86
2025 Q3	$1.35M	Buy	5,812 +525	+10%	+$107K	0.16%	79
2025 Q2	$981K	Buy	5,287 +445	+9%	+$82.7K	0.13%	87
2025 Q1	$1.01M	Hold	4,842	–	–	0.16%	83
2024 Q4	$860K	Sell	4,842 -25	-0.5%	-$4.6K	0.14%	89
2024 Q3	$961K	Sell	4,867 -14	-0.3%	-$2.61K	0.17%	83
2024 Q2	$837K	Sell	4,881 -138	-3%	-$22.9K	0.15%	83
2024 Q1	$914K	Sell	5,019 -382	-7%	-$65.8K	0.16%	76
2023 Q4	$872K	Sell	5,401 -66	-1%	-$9.62K	0.16%	75
2023 Q3	$815K	Sell	5,467 -426	-7%	-$62.5K	0.16%	80
2023 Q2	$847K	Sell	5,893 -565	-9%	-$82.9K	0.16%	80
2023 Q1	$1.03M	Buy	6,458 +1,480	+30%	+$226K	0.21%	68
2022 Q4	$804K	Buy	4,978 +300	+6%	+$46K	0.17%	80
2022 Q3	$628K	Buy	4,678 +4,000	+590%	+$574K	0.14%	87
2022 Q2	$104K	Hold	678	–	–	0.02%	229
2022 Q1	$110K	Sell	678 -33	-5%	-$4.79K	0.02%	219
2021 Q4	$96K	Sell	711 -37	-5%	-$4.37K	0.02%	228
2021 Q3	$81K	Buy	+748	New	+$85.5K	0.02%	230
2021 Q2	–	Sell	-748	Closed	-$81K	–	183
2021 Q1	$81K	Hold	748	–	–	0.02%	218
2020 Q4	$80K	Buy	+748	New	+$71.9K	0.02%	247

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Destiny Wealth Partners's ABBV Position: Q2 2026 in Review

Destiny Wealth Partners reduced its AbbVie (ABBV) stake by 8.9% in Q2 2026, selling an estimated $106K and leaving 5,066 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #65.

Destiny Wealth Partners first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.35M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Destiny Wealth Partners held 5,066 shares of AbbVie worth $1.27M as of Q2 2026.
Destiny Wealth Partners sold 495 AbbVie shares in Q2 2026, an estimated $106K.
AbbVie made up 0.18% of Destiny Wealth Partners's portfolio in Q2 2026, its #65 holding.
Destiny Wealth Partners first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
Destiny Wealth Partners's AbbVie position peaked at $1.35M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.